Number of Shares
2,457.00
Current Holdings Value*
$1.19 Mil
% of Portfolio
2.75%
Total Estimate Gain
$2.61 Mil
% of Total Estimate Gain
120.92%

AlphaCentric Life Sciences and Healthcare Fund's Vertex Pharmaceuticals Inc Holding Summary

As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 2,457.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $1.19 Mil. This investment constitutes 2.75% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.

The initial trade took place in 2020Q1. And since then AlphaCentric Life Sciences and Healthcare Fund has made 6 purchases of VRTX, at an average price of $210.17, for a total of 10,250.00 shares. In addition, there have been 1 sales at an average price of $463.64 for 7,793.00 shares. Based on historical transaction data and VRTX's current price of $466.47, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his VRTX holdings is $2.61 Mil, reflecting a 120.92% gain to date.

AlphaCentric Life Sciences and Healthcare Fund VRTX ($466.47) Holding Chart

AlphaCentric Life Sciences and Healthcare Fund VRTX ($466.47) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1